GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gujarat Themis Biosyn Ltd (BOM:506879) » Definitions » EV-to-FCF

Gujarat Themis Biosyn (BOM:506879) EV-to-FCF : (As of Mar. 25, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Gujarat Themis Biosyn EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Gujarat Themis Biosyn's Enterprise Value is ₹31,633 Mil. Gujarat Themis Biosyn's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil. Therefore, Gujarat Themis Biosyn's EV-to-FCF for today is .

The historical rank and industry rank for Gujarat Themis Biosyn's EV-to-FCF or its related term are showing as below:

BOM:506879' s EV-to-FCF Range Over the Past 10 Years
Min: -399.93   Med: 0   Max: 187.73
Current: -255.71

During the past 13 years, the highest EV-to-FCF of Gujarat Themis Biosyn was 187.73. The lowest was -399.93. And the median was 0.00.

BOM:506879's EV-to-FCF is ranked worse than
100% of 549 companies
in the Drug Manufacturers industry
Industry Median: 23.27 vs BOM:506879: -255.71

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-25), Gujarat Themis Biosyn's stock price is ₹291.65. Gujarat Themis Biosyn's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹4.830. Therefore, Gujarat Themis Biosyn's PE Ratio (TTM) for today is 60.38.


Gujarat Themis Biosyn EV-to-FCF Historical Data

The historical data trend for Gujarat Themis Biosyn's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gujarat Themis Biosyn EV-to-FCF Chart

Gujarat Themis Biosyn Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -56.43 34.86 21.63 62.68 -274.71

Gujarat Themis Biosyn Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -274.71 - - -

Competitive Comparison of Gujarat Themis Biosyn's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Gujarat Themis Biosyn's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gujarat Themis Biosyn's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gujarat Themis Biosyn's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Gujarat Themis Biosyn's EV-to-FCF falls into.



Gujarat Themis Biosyn EV-to-FCF Calculation

Gujarat Themis Biosyn's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=31632.595/0
=

Gujarat Themis Biosyn's current Enterprise Value is ₹31,633 Mil.
Gujarat Themis Biosyn's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gujarat Themis Biosyn  (BOM:506879) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Gujarat Themis Biosyn's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=291.65/4.830
=60.38

Gujarat Themis Biosyn's share price for today is ₹291.65.
Gujarat Themis Biosyn's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹4.830.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Gujarat Themis Biosyn EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Gujarat Themis Biosyn's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Gujarat Themis Biosyn Business Description

Traded in Other Exchanges
Address
S.V Road, Themis House, 11/12 Udyog Nagar, Goregaon (West), Mumbai, MH, IND, 400104
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.

Gujarat Themis Biosyn Headlines

No Headlines